Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Microarrays & Multiplexing » Alcohol Abuse Genetic Study Implicates Additional Variants in Risk of Problem Drinking

Alcohol Abuse Genetic Study Implicates Additional Variants in Risk of Problem Drinking

May 26, 2020
|
staff reporter

NEW YORK – Researchers have tied 19 novel genetic risk variants to problematic drinking in a new genome-wide meta-analysis.

While a number of risk variants have previously been linked to alcohol use disorder and problematic drinking, researchers led by Yale School of Medicine's Joel Gelernter conducted a meta-analysis of more than 435,000 individuals to search for additional risk loci. Alcohol use is a leading risk factor for death, leading to 2.8 million deaths in 2016, according to a Global Burden of Disease Study.  

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

To Keep Up

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

On the Rise in the City

The New York Times reports that a new viral variant of concern has been identified in New York City.

Nature Studies Present Single-Cell Map of Cell Cycle, Approach Identifies Cancer Treatment Resistance Pathways, More

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

Support for Another

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Mar
16
Featured Webinar

The Predictive Power of Poop: COVID-19 Wastewater Surveillance to Inform Public Health Decisions in Colorado

Sponsored by
Bio-Rad

Wastewater based epidemiology (WBE) has been established as a viable, valuable, and cost-effective means to monitor infectious disease within a community. 

Mar
23
Featured Webinar

ctDNA MRD Detection and Personalized Oncogenomic Analysis in Colorectal Cancer

Sponsored by
Roche

This webinar will discuss findings from the study, in which molecular residual disease (MRD) was assessed using circulating tumor DNA (ctDNA) without prior mutational knowledge in oligometastatic colorectal cancer (CRC) patients who had received neoadjuvant chemotherapy. This study also investigated urine as an alternative analyte for ctDNA MRD detection.

What's Popular?

In Genetic Research

  1. Haplotype-Resolved Human Genomes Help Complete Picture of Structural Variants

  2. Cytox Gets CE Mark for Alzheimer's Disease Genetic Risk Test

  3. Glaucoma GWAS Meta-Analysis Uncovers New Risk Loci, Shared Risk Across Ancestry Groups

  4. Population History of East Asia Unveiled in Genomic Study

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.